Search
Animal Health Partnering Interests Oncology May 2024 CORP
Animal Health Partnering Interests CNS Diseases May 2024 CORP
Animal Health Partnering Interests Pain & Mobility May 2024 CORP
Animal Health Partnering Interests Parasitology May 2024 CORP
Animal Health Partnering Interests Immunology & Inflammation May 2024 CORP
Animal Health Partnering Interests Technologies May 2024 CORP
Animal Health Partnering Interests Digital Science May 2024 CORP
Worldwide Contacts Animal Health Partnering May 2024
Animal Health Partnering Guide.pdf
Animal Health Partnering Outlook
Partnering with Animal Health MAY 2024 CORP_0.pdf
BI_Animal_Health.pdf
190326_BI_Beethoven_Infographic_Animal-Human-Health_Final.pdf
190326_BI_Beethoven_Infographic_Animal-Human-Health_Final.pdf
Boehringer Ingelheim Animal Health Business Unit Factsheet_2.pdf
Annual Results Press Conference
Boehringer Ingelheim presents the results of business development and gives an outlook for the coming year.
Questions and Answers
Answers to common questions from both patients and health care professionals regarding Compassionate Use of experimental medications.
Boehringer Ingelheim announces appointments Board of Managing Directors
Boehringer Ingelheim announces appointments Board of Managing Directors
Boehringer Ingelheim announces collaboration with MabGenesis
Boehringer Ingelheim announces collaboration with MabGenesis to discover and develop novel monoclonal antibodies in canine
Global Top Employer 2023
Global Top Employer 2023
Collaboration Boehringer Ingelheim Veeva technology
Boehringer Ingelheim selects Veeva Development Cloud worldwide to bring innovative therapies to patients faster
Our partners university of georgia
We're partnering with the University of Georgia to address unmet needs and find solutions to some of the biggest challenges in animal health.
Mental Health
Human Pharma Clinical Pipeline Mental Health therapeutic area
Boehringer expands production site in Greece
Boehringer expands production site in Greece for new medicine